{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiarjiyejwnevp425neth7br2b7qdgcxrmuv44kp7folfmuygcyedq",
    "uri": "at://did:plc:4kwqvtwyj7nywt3v7ra2cuy4/app.bsky.feed.post/3mf44lcpgzz42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihfuxxfa35q7eo6qxsnmosuce3vocxrtmhjmqd2rp4jplthg4o2vq"
    },
    "mimeType": "image/jpeg",
    "size": 149111
  },
  "path": "/content/2c72c0e6-147d-4c53-9008-0d47cb63c085",
  "publishedAt": "2026-02-18T01:15:07.000Z",
  "site": "https://www.ft.com",
  "textContent": "Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’",
  "title": "Beijing backs brain implant push to rival Elon Musk’s Neuralink"
}